These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7940945)

  • 1. Pharmacokinetic profile of cyclosporine in long-term heart transplanted patients treated with a new oral formulation.
    Fiocchi R; Mamprin F; Gamba A; Glauber M; Catania S; Cattaneo G; Torre L; Bertocchi C; Ruhrmann R; Colombo D
    Transplant Proc; 1994 Oct; 26(5):2994-5. PubMed ID: 7940945
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of Neoral in heart transplant recipients.
    Mikhail G; Eadon H; Leaver N; Yacoub M
    Transplant Proc; 1994 Oct; 26(5):2985-7. PubMed ID: 7940943
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients.
    Schiavelli R; Sgrosso JL; Sabbatiello R; Castro C; Ahualli L; Pattin M; Vazquez MC
    Transplant Proc; 1996 Dec; 28(6):3343-4. PubMed ID: 8962299
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients.
    Diliz HS; Olivera MA; Kershenobich D; Mercado MA; Orozco H
    Transplant Proc; 1996 Dec; 28(6):3348-50. PubMed ID: 8962302
    [No Abstract]   [Full Text] [Related]  

  • 6. Changing stable heart transplant recipients from Sandimmune to Neoral.
    Dalrymple-Hay M; Meara M; Reynolds L; Backhouse L; Wright D; Holt D; Johnston A; Madden B; Murday A
    Transplant Proc; 1996 Aug; 28(4):2285-6. PubMed ID: 8769227
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.
    White M; Pelletier GB; Tan A; Jesina C; Carrier M
    J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
    Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet and cyclosporin A--pharmacokinetic comparison between Neoral and Sandimmune gelatin capsules.
    Browne BJ; Jordan S; Welsh MS; Van Buren C; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):2959-60. PubMed ID: 7940934
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood cyclosporin A and metabolite kinetic profiles after administration of Sandimmune soft gelatine capsules and Neoral in transplant recipients.
    Vernillet L; Kovarik JM; Freiburghaus R; Schaub P; Mueller EA; Niederberger W; Zehender H
    Transplant Proc; 1994 Oct; 26(5):2964-8. PubMed ID: 7940936
    [No Abstract]   [Full Text] [Related]  

  • 11. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application?
    Haller GW; Winkler M; Bechstein WO; Oldhafer KJ; Ringe B; Maibücher A; Färber L; Pichlmayr R; Neuhaus P
    Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of a new galenical formulation of oral cyclosporine A in stable kidney transplanted patients.
    Foradori AC; Martínez L; Vacarezza A; Elberg L; Loveluck A; Pinto C
    Transplant Proc; 1994 Oct; 26(5):2969-72. PubMed ID: 7940937
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients.
    Svendsen UG; Larsen KR; Allermand H; Thayssen P; Jensen SB; Pettersson G
    Transplant Proc; 1996 Aug; 28(4):2281. PubMed ID: 8769225
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term results with cyclosporine monotherapy after heart transplantation.
    Koerner MM; Posival H; Tenderich G; el-Banayosy A; Koertke H; zu Knyphausen E; Kleesiek K; Meyer H; Koerfer R
    Transplant Proc; 1994 Oct; 26(5):2718-20. PubMed ID: 7940851
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion from regular cyclosporine to microemulsion cyclosporine following heart transplantation.
    Heroux AL; LeBlanc MH; Beaudoin D; Simard S; Coulombe DA; Gleeton O; Lemieux MD; Doyle DP
    Transplant Proc; 1996 Dec; 28(6):3145-8. PubMed ID: 8962219
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term results of conversion from existing to microemulsion formulation of cyclosporine.
    Neumayer HH; Färber L; Budde K; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
    Transplant Proc; 1996 Aug; 28(4):2207-13. PubMed ID: 8769202
    [No Abstract]   [Full Text] [Related]  

  • 17. Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral.
    Ritschel WA
    Clin Transplant; 1996 Aug; 10(4):364-73. PubMed ID: 8884110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favourable clinical results of Sandimmun-Neoral in malabsorbing liver and heart transplant recipients.
    Färber L; Maibücher A; Geissler F; Gutzler F; Wiesinger FO; Winkler M
    Transplant Proc; 1994 Oct; 26(5):2988-93. PubMed ID: 7940944
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoral in liver transplant patients: pharmacokinetic study and clinical implications.
    Belli LS; Slim OA; De Carlis L; Rondinara GF; Alberti A; Zoppi F; Bellati G; Fesce E; Airoldi A; Colombo D
    Transplant Proc; 1994 Oct; 26(5):2981-2. PubMed ID: 7940941
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary pharmacokinetic evaluation of a new galenical formulation of oral cyclosporine A: Neoral TM.
    Foradori AC; Martínez L; Elberg A; Vaccarezza A; Loveluck A; Pinto C
    Transplant Proc; 1995 Apr; 27(2):1813-4. PubMed ID: 7725515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.